Srinivas Sadu appointed as Executive Chairman and CEO of Gland Pharma Ltd

Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024.

Srinivas Sadu, a seasoned professional with over two decades of rich experience, has been a key part of Gland's journey. He assumed the role of MD and CEO on April 25, 2019, and has been instrumental in the company's growth and success. His career with the company began in 2000, and he steadily rose through the ranks to become chief operating officer in 2011.

Shares of Gland Pharma Limited was last trading in BSE at Rs. 1856.00 as compared to the previous close of Rs. 1836.75. The total number of shares traded during the day was 8553 in over 1219 trades.

The stock hit an intraday high of Rs. 1866.00 and intraday low of 1829.00. The net turnover during the day was Rs. 15829076.00.

Source : Equity Bulls

Keywords

GlandPharma INE068V01023 Appointment CEO ExecutiveChairman